| Code | 5867D | ||||||||||
| MA number | 07/0252/20-S | ||||||||||
| Product Form: | sol inf 20x400 mg/100 ml (fľ.LDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Fresenius Kabi s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 07 - ANALGETICA, ANTIPYRETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | bottle LDPE | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 30.11.2020 |
| SPC: |
SPC_Ibuprofen Kabi 400 mg_11.2024.pdf
|
| PIL: |
PIL_Ibuprofen Kabi 400 mg_11.2024.pdf
|
| Safety feature | Yes |
| Data update: | 31.03.2025 |
